What if the real doctor is already in your intestine?
Several years ago a medical friend of mine, the Roman oncologist Tullio Simoncini, told me a phrase that I never forgot: "The real black hole in medicine is the intestine. Many diseases start from there, yet it is one of the organs that we understand less. "
Beyond provocation, in recent years scientific research has actually begun to recognize the central role of the intestine in the general health of the body. Today we know that the intestinal microbiota affects the immune system, metabolism, inflammation, neurotransmitter production and even some brain functions. Yet there are few people who can claim to have a bowel that actually works optimally. Inflator, slow digestion, constipation, irregular alvo, recurrent diarrhea, reflux and intestinal disorders of various nature have become so common to be considered almost normal. Many live for years with these problems without giving them particular importance, gradually becoming accustomed to a condition which, in reality, often represents a signal of imbalance.
With the passing of time, however, these discomforts may accompany the appearance of other issues: chronic inflammation, weight gain, metabolic alterations, reduction of immune defenses and numerous other disorders that modern research increasingly connects to intestinal health. For this reason, taking care of the intestine does not simply mean improving digestion, but investing in the health of the whole organism. Today more than ever it appears obvious that understanding and protecting microbiota could be one of the most important keys for the prevention of many chronic diseases.
In recent years the scientific world has begun to focus its attention on a tiny bacteria of our intestine which, until recently, was practically unknown. His name is Akkermansia muciniphila and many researchers today consider it one of the most promising discoveries in the field of microbiota medicine. If until a few years ago we were talking almost exclusively about lactobacils and bifidobacteria, today the interest of research is moving towards this particular mycr body, which seems to play a fundamental role in the protection of the intestine and in the maintenance of the metabolic balance of the entire organism.
Akkermansia muciniphila is a bacteria naturally present in the human intestine. He was first identified in 2004 by the Dutch microbiologist Willem de Vos and owes his name to the microbiologist Anton Akkermans. Its most striking feature is to live within the mucus layer that covers the intestinal wall and to feed itself precisely to the kitchen, the substance that constitutes this precious protective barrier. At first glance it might seem like a harmful behavior, but it actually happens exactly the opposite. Consuming a part of the kitchen, Akkermansia continuously stimulates the organism to produce new ones, thus contributing to the renewal and maintenance of an efficient intestinal barrier.
In healthy individuals this bacterium normally represents a share between one and four percent of the entire intestinal microbiota. What attracted the attention of the scientific community is the fact that its levels are often reduced in people suffering from obesity, type 2 diabetes, metabolic syndrome, fat liver, intestinal inflammatory diseases and numerous other conditions characterized by chronic inflammation. This observation prompted researchers to wonder whether the increase in Akkermansia could help improve certain health parameters and, in recent years, numerous studies have begun to provide very interesting answers.
One of the main benefits attributed to this bacterium is the strengthening of the intestinal barrier. The intestine is not only a nutrient absorption organ, but also one of the most important defence lines of the body. When the intestinal mucosa loses its integrity, unwanted substances such as bacterial toxins, fragments of microorganisms and inflammatory molecules can cross it and reach the bloodstream. This phenomenon, often referred to as an increase in intestinal permeability, has been associated with numerous chronic diseases. Akkermansia seems to help maintain this barrier in optimal conditions, limiting the passage of potentially harmful substances and favoring a better immune balance. Research has also shown interesting effects on sugar metabolism. In a clinical study published in the prestigious Nature Medicine magazine, overweight and obese subjects who hired Akkermansia for three months showed an improvement of insulin sensitivity, a reduction in circulating insulin levels and an improvement of different metabolic parameters. In other words, the cells of the body have become more efficient in using blood glucose, a particularly important feature in the prevention and management of type 2 diabetes.
Also body weight control seems to be influenced by the presence of this bacteria. Several studies have observed that people with higher levels of Akkermansia tend to accumulate less visceral fat, what settles around the internal organs and is considered the most dangerous from the metabolic point of view. Some researches have also highlighted a greater ease in maintaining the weight achieved after a slimming diet, suggesting that this microorganism can play an important role in countering the so-called yo-yo effect, one of the main problems of those seeking to lose weight.
Particularly interesting is also the possible involvement of Akkermansia in cardiovascular health. Although there is still no evidence that demonstrate a direct reduction of atherosclerotic plaques in man, several studies have documented improvements in the metabolic profile, reductions in systemic inflammation and improved management of lipid metabolism. Since inflammation, insulin-resistance, obesity and alterations of fat metabolism are important factors of cardiovascular risk, maintaining adequate levels of Akkermansia could indirectly contribute to the protection of the cardiovascular system. In recent years, interest in its role has also grown in hepatic steatosis, commonly known as fat liver. Research suggests that a microbiota rich in Akkermansia can promote better hepatic fat management, reduce liver inflammation and improve some metabolic parameters associated with this increasingly widespread condition. Surely readers will wonder where this particular probiotic is from. Akkermansia is a bacteria naturally present in the human intestine and the supplements available on the market are produced through sophisticated biotechnological processes that allow it to be cultivated in controlled environments. Curiously, clinical studies have shown that the most effective form is not the living one but the pasteurized one. The biologically active components of the bacteria are preserved through special heat treatment, improving stability, safety and effectiveness.
When we talk about dosages we need to make an important clarification. Unlike vitamins or minerals, probiotics are normally expressed in number of cells and not in milligrams. In human clinical studies, doses between 10 and 30 billion cells per day were generally used. Converting these quantities into milligrams is not possible precisely, because the weight varies according to the method of production and concentration of the product. For this reason, experts recommend that you follow the indications on the selected supplement, always checking the number of cells declared by the manufacturer. In practice, many protocols utilize products that provide about 10 billion cells per day for cycles lasting eight to twelve weeks, while some supplements come to provide 30 billion cells per day in the most intensive programs. The evaluations carried out by the European Food Safety Authority have confirmed a good safety profile at doses normally used in clinical trials.
However, there is an even more natural strategy to increase the presence of Akkermansia in the intestine: to create the conditions that promote its growth. Numerous researches have shown that this bacteria thrives in the presence of foods rich in polyphenols and prebiotic fibers. Pomegranate, blueberries, red grapes, dark cocoa, green tea, onions, garlic and inulin-rich foods seem to favour its development. Even the intermittent fasting, if properly applied and compatible with individual conditions, was associated with an increase in its presence in the microbiota. On the contrary, refined sugars, ultra-processed foods and particularly unbalanced diets tend to reduce their quantity.
Until a few years ago Akkermansia muciniphila was practically unknown; today it is considered one of the most promising intestinal bacteria and studied by scientific research. Although it is not a miracle cure or solution to all diseases, the evidence available indicates that it plays an important role in maintaining intestinal health, in regulating inflammation and in the proper functioning of metabolism. Not a magic wand, therefore, but a potential help for our well-being.
Main scientific studies on Akkermansia muciniphila
In recent years Akkermansia muciniphila has been the subject of a growing number of scientific publications. Below are some of the most important clinical studies available today.
Depommier C. et al., Nature Medicine, 2019
It is the first man-controlled clinical study that evaluated the safety and effectiveness of Akkermansia muciniphila in overweight and obese subjects with metabolic alterations. After three months of integration, researchers observed an improvement of insulin sensitivity, a reduction in circulating insulin, a decrease in total cholesterol and an improvement of different metabolic parameters. The study also showed that the pasteurized form of the bacterium is more effective than the living one.
Mount S. et al., Nature Medicine, 2026
In this controlled randomized study 90 overweight or obese subjects were involved who had lost at least 8% of their body weight through a hypocaloric diet. After six months, the group taking Akkermansia pasteurized had recovered on average only 1.2 kg, compared to 3.2 kg of the placebo group. In addition, a better conservation of the metabolic benefits obtained with slimming was observed. No serious adverse effects related to treatment have been reported.
Research on microbiota and metabolic syndrome
Several scientific works have shown that people with obesity, type 2 diabetes and metabolic syndrome frequently have reduced levels of Akkermansia muciniphila. The integration of the bacteria seems to help improve the functionality of the intestinal barrier, reduce inflammation and promote better metabolic control.
Akkermansia and body weight maintenance
The latest research indicates that Akkermansia could be an innovative strategy to limit weight loss after a slimming diet. The benefits seem to be particularly noticeable in people with low intestinal levels of bacteria before the beginning of integration.
Essential Bibliography
Depommier C. et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nature Medicine, 2019.
Anhê F.F., Schertzer J.D., Marette A. Bacteria to alleviate metabolic syndrome. Nature Medicine, 2019.
Mount S. et al. Pasteurized Akkermansia muciniphila MucT for weight loss maintenance in people with overweight and obesity: a controlled randomized trial. Nature Medicine, 2026.
A. Keeping off the weight with Akkermansia. Nature Reviews Microbiology, 2026.


